Skip to main content

Table 2 Comparison among two strategies for severe asthma treatment concerning health care utilization, quality of life and asthma control (n = 64)

From: Cost-effectiveness analysis of a state funded programme for control of severe asthma

 

year before ProAR

year after ProAR

 

Health care utilization per patient

median (quartiles)

median (quartiles)

p*

   Regular specialist visits

0 (0/0)

9 (6/12)

< 0.01

   Spirometries performed

1 (0/1)

2 (2/2)

< 0.01

   Emergency/unscheduled visits

36 (6/120)

1 (0/3)

< 0.01

   Hospitalizations

1 (0/2)

0 (0/0)

< 0.01

Quality of life

   

   Total AQLQ score

2 (2/3)

4 (3/6)

< 0.01

Asthma control

   

   ACQ scores

4 (3/5)

2 (0.6/3)

< 0.01

   % of expected FEV1

69 (49/82)

76 (58/84)

0.560

   % of expected PEF

45 (34/66)

66 (49/83)

< 0.01

  1. * Wilcoxon Signed Rank Test